4.3 Article

DNA damage checkpoint inactivation: Adaptation and recovery

Journal

DNA REPAIR
Volume 8, Issue 9, Pages 1101-1109

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.dnarep.2009.04.008

Keywords

DNA damage checkpoint; Adaptation; Recovery; Saccharomyces cerevisiae; Yeast

Funding

  1. Association pour la Recherche Sur le Cancer(ARC)
  2. Agence Nationale de la Recherche (ANR)

Ask authors/readers for more resources

The DNA damage checkpoint is a stress response pathway detecting pathological structures of nuclear DNA and inducing appropriate responses. These responses include cell cycle arrests, histone modifications, changes in the transcription programme and post-translational modifications of proteins involved in DNA repair. Inactivation of the DNA damage checkpoint responses can occur under two circumstances: either DNA damage has disappeared and the whole pathway is inactivated in a process termed recovery, or DNA damage persists but all or part of the pathway is nevertheless inactivated, which is called adaptation. We present here a review of these inactivating processes of the DNA damage checkpoint primarily in the budding yeast Saccharomyces cerevisiae but also with reference to studies in Schizosaccharomyces pombe and in animal cells. (C) 2009 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Meeting Abstract Oncology

S49076, a MET, AXL, FGFR inhibitor, potentiates radiation therapy in subcutaneous and orthotopic models of lung cancer

Celine Clemenson, Cyrus Chargari, Michele Mondini, Charles Ferte, Winchygn Liu, Mike Burbridge, Valerie Cattan, Anne Jacquet-Bescond, Eric Deutsch

CANCER RESEARCH (2015)

Article Oncology

Synergy of Radiotherapy and a Cancer Vaccine for the Treatment of HPV-Associated Head and Neck Cancer

Michele Mondini, Mevyn Nizard, Thi Tran, Laetitia Mauge, Mauro Loi, Celine Clemenson, Delphine Dugue, Pierre Maroun, Emilie Louvet, Julien Adam, Cecile Badoual, Dominique Helley, Estelle Dransart, Ludger Johannes, Marie-Catherine Vozenin, Jean-Luc Perfettini, Eric Tartour, Eric Deutsch

MOLECULAR CANCER THERAPEUTICS (2015)

Article Biotechnology & Applied Microbiology

Cytotoxic effect of lapatinib is restricted to human papillomavirus-positive head and neck squamous cell carcinoma cell lines

Ingrid Fumagalli, Delphine Dugue, Jean Emmanuel Bibault, Celine Clemenson, Marie Catherine Vozenin, Michele Mondini, Eric Deutsch

ONCOTARGETS AND THERAPY (2015)

Article Oncology

The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy

Celine Clemenson, Cyrus Chargari, Winchygn Liu, Michele Mondini, Charles Ferte, Mike F. Burbridge, Valerie Cattan, Anne Jacquet-Bescond, Eric Deutsch

MOLECULAR CANCER THERAPEUTICS (2017)

Article Multidisciplinary Sciences

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors

Bertrand Routy, Emmanuelle Le Chatelier, Lisa Derosa, Connie P. M. Duong, Maryam Tidjani Alou, Romain Daillere, Aurelie Fluckiger, Meriem Messaoudene, Conrad Rauber, Maria P. Roberti, Marine Fidelle, Caroline Flament, Vichnou Poirier-Colame, Paule Opolon, Christophe Klein, Kristina Iribarren, Laura Mondragon, Nicolas Jacquelot, Bo Qu, Gladys Ferrere, Celine Clemenson, Laura Mezquita, Jordi Remon Masip, Charles Naltet, Solenn Brosseau, Coureche Kaderbhai, Corentin Richard, Hira Rizvi, Florence Levenez, Nathalie Galleron, Benoit Quinquis, Nicolas Pons, Bernhard Ryffel, Veronique Minard-Colin, Patrick Gonin, Jean-Charles Soria, Eric Deutsch, Yohann Loriot, Francois Ghiringhelli, Gerard Zalcman, Francois Goldwasser, Bernard Escudier, Matthew D. Hellmann, Alexander Eggermont, Didier Raoult, Laurence Albiges, Guido Kroemer, Laurence Zitvogel

SCIENCE (2018)

Review Pharmacology & Pharmacy

Understanding the functions of tumor stroma in resistance to ionizing radiation: Emerging targets for pharmacological modulation

Cyrus Chargari, Celine Clemenson, Isabelle Martins, Jean-Luc Perfettini, Eric Deutsch

DRUG RESISTANCE UPDATES (2013)

Article Oncology

The vascular disrupting agent ombrabulin (AVE8062) enhances the efficacy of standard therapies in head and neck squamous cell carcinoma xenograft models

Celine Clemenson, Erwan Jouannot, Ana Merino-Trigo, Chantal Rubin-Carrez, Eric Deutsch

INVESTIGATIONAL NEW DRUGS (2013)

Article Oncology

Leukemia-initiating cell activity requires calcineurin in T-cell acute lymphoblastic leukemia

S. Gachet, E. Genesca, D. Passaro, M. Irigoyen, H. Alcalde, C. Clemenson, S. Poglio, F. Pflumio, A. Janin, C. Lasgi, S. Dodier, M. Soyer, G. Dumenil, J. Ghysdael

LEUKEMIA (2013)

Meeting Abstract Oncology

Novel MET/FGFR/AXL kinase inhibitor S49076 exerts radiosensitizing activity in vitro and in vivo.

Cyrus Chargari, Celine Clemenson, Michele Mondini, Charles Ferte, Anne Jacquet-Bescond, Valerie Cattan, Stephane Depil, Eric Deutsch

MOLECULAR CANCER THERAPEUTICS (2013)

Article Oncology

IGF-1R Targeting Increases the Antitumor Effects of DNA-Damaging Agents in SCLC Model: An Opportunity to Increase the Efficacy of Standard Therapy

Charles Ferte, Yohann Loriot, Celine Clemenson, Frederic Commo, Andrea Gombos, Jean-Emmanuel Bibault, Ingrid Fumagalli, Saad Hamama, Nathalie Auger, Benoit Lahon, Cyrus Chargari, Julien Calderaro, Jean-Charles Soria, Eric Deutsch

MOLECULAR CANCER THERAPEUTICS (2013)

Article Oncology

CCR2-Dependent Recruitment of Tregs and Monocytes Following Radiotherapy Is Associated with TNFα-Mediated Resistance

Michele Mondini, Pierre-Louis Loyher, Pauline Hamon, Marine Gerbe de Thore, Marie Laviron, Kevin Berthelot, Celine Clemenson, Benoit L. Salomon, Christophe Combadiere, Eric Deutsch, Alexandre Boissonnas

CANCER IMMUNOLOGY RESEARCH (2019)

Article Oncology

Preventing Radiation-Induced Injury by Topical Application of an Amifostine Metabolite-Loaded Thermogel

Celine Clemenson, Winchygn Liu, Denis Bricout, Loren Soyez-Herkert, Cyrus Chargari, Michele Mondini, Raphael Haddad, Xiuping Wang-Zhang, Laurent Benel, Christian Bloy, Eric Deutsch

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

Article Oncology

Differential therapeutic effects of PARP and ATR inhibition combined with radiotherapy in the treatment of subcutaneous versus orthotopic lung tumour models

Vanessa Tran Chau, Winchygn Liu, Marine Gerbe de Thore, Lydia Meziani, Michele Mondini, Mark J. O'Connor, Eric Deutsch, Celine Clemenson

BRITISH JOURNAL OF CANCER (2020)

Article Oncology

Dual oxidase 1 limits the IFNγ-associated antitumor effect of macrophages

Lydia Meziani, Marine Gerbe de Thore, Pauline Hamon, Sophie Bockel, Ruy Andrade Louzada, Celine Clemenson, Raphael Corre, Wincgygn Liu, Corinne Dupuy, Michele Mondini, Eric Deutsch

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Meeting Abstract Oncology

CCL2/CCR2-driven monocyte recruitment to the tumor following radiotherapy influences the outcome of the treatment of head and neck cancer

Michele Mondini, Pierre L. Loyher, Kevin Berthelot, Celine Clemenson, Alexandre Boissonnas, Eric Deutsch

CANCER RESEARCH (2017)

Article Genetics & Heredity

The impact of chromatin on double-strand break repair: Imaging tools and discoveries

Marit A. E. van Bueren, Aniek Janssen

Summary: Eukaryotic nuclei rely on multiple repair pathways to accurately repair DNA damage, particularly in chromatin domains enriched for repetitive DNA sequences. Tailored repair mechanisms are necessary to maintain genome stability in these domains.

DNA REPAIR (2024)